
Cambridge Isotope Labs, Chemtatva Chiral Solutions join hands to set up facility in Telangana
The Hindu
Cambridge Isotope Labs and Chemtatva Chiral Solutions invest ₹300 crore in Telangana for advanced manufacturing and job creation.
U.S. firm Cambridge Isotope Laboratories in collaboration with Hyderabad-based Chemtatva Chiral Solutions has decided to establish advanced manufacturing capabilities in Telangana.
Their joint venture plans to invest around ₹300 crore over the next three years in Genome Valley Phase 4, creating over 250 direct, high-skilled jobs and strengthen India’s position in manufacturing isotopically labelled molecules used in pharmaceutical research, diagnostics, advanced electronics, OLED materials, and semiconductor applications.
Telangana Life Sciences announced this after the leadership team of the companies met IT and Industries Minister D. Sridhar Babu. The proposed investment will strengthen capabilities in advanced chemistry and materials, the Minister said in a release.
A wide range of stable isotope–labelled compounds that are critical for drug discovery, metabolic studies, diagnostics, and advanced materials research will be manufactured at the proposed facility. The investment will also help reduce India’s dependence on imports in this highly specialised segment, Telangana Life Sciences CEO Shakthi M. Nagappan said.
Stable isotopes and labelled molecules are essential tools for modern pharmaceutical research, diagnostics and emerging electronics applications, he said. The companies chose Telangana, citing the strong life sciences ecosystem, availability of skilled scientific talent, robust infrastructure and proactive government support for advanced manufacturing sectors in the State.
Cambridge Isotope Laboratories CEO Cliff Caldwell sought to highlight the strong ecosystem for advanced chemistry and Life Sciences manufacturing backed by skilled scientific workforce and progressive policies in Telangana.













